meta-x.com

What It Is

Meta-Xceed, Inc. is a U.S.-based clinical analytics software and consulting provider founded in 1997. Its company information indicates a headquarters in California, with outsourcing capabilities in Vietnam. It primarily serves pharmaceutical, biotech, CRO, and medical device companies, offering software and services around clinical trial data, SAS programming, biostatistics, CDISC standards, system validation, and regulatory electronic submissions.

Core Features and Integrations

Its product line includes Transdata, CDISC Builder, Definedoc, Sy/Validate, ThesQA, Sy/Tools, and Trialex. Transdata is used to convert SAS data into standard structures; CDISC Builder helps create CDISC submission datasets; Definedoc generates DEFINE.XML and PDF documentation; Sy/Validate focuses on SAS program validation, version control, and audit trails; and ThesQA is used for quality management of adverse event and drug dictionary mappings. The ecosystem is clearly centered on SAS, with references to SAS Alliance Partner, SAS Grid/Cluster, SAS macro libraries, MS Office/Excel/Word plugins, and terminology systems such as MedDRA, WHO-Drug, and Costart.

Pricing, Deployment, and Compliance

The captured text does not disclose plans, licensing models, pricing, payment methods, or an official free trial policy, though some modules mention demos. In terms of deployment, Trialex is described as a web-based clinical metadata management system, but it is not clear whether the overall offering is cloud SaaS or on-premises. Compliance is one of its main selling points: the text repeatedly mentions CDISC, CFR Part 11, data integrity, SAS program auditing, version control, change control, and system validation. However, it does not provide details on encryption, permission models, SOC/ISO certifications, or other security specifics.

Pros, Cons, and Best Fit

Its strengths are its deep industry focus and coverage of key clinical data workflows such as SDTM, ADaM, DEFINE.XML/PDF, TLG, SAS validation, and FDA submissions, along with the ability to combine consulting and custom development. The downsides are that the website information appears dated and repetitive, while product boundaries, versions, deployment options, permissions, APIs, and service SLAs are unclear. It also lacks the transparency expected from modern SaaS products. It is better suited to pharmaceutical companies and CROs that already operate a SAS environment and need CDISC compliance and submission support, rather than general-purpose data analytics teams.

Access from China and Alternatives

Access from China cannot be determined from the available text and should be treated as unknown. For use in mainland China, key points to verify include network connectivity, cross-border data compliance, contract payment arrangements, support for local deployment, and Chinese-language service availability. Comparable options include SAS life sciences solutions, Pinnacle 21, Certara, Medidata, Oracle Clinical One, as well as domestic clinical data management and regulatory submission service providers.